Published in J Am Soc Nephrol on September 02, 2010
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46
Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12
Through a glass darkly: seeking clarity in preventing late kidney transplant failure. J Am Soc Nephrol (2014) 1.07
MR elastography in renal transplant patients and correlation with renal allograft biopsy: a feasibility study. Acad Radiol (2012) 0.99
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98
Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol (2013) 0.91
Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev (2014) 0.88
Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function. Transplantation (2012) 0.87
Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol (2012) 0.87
Differential Ly6C Expression after Renal Ischemia-Reperfusion Identifies Unique Macrophage Populations. J Am Soc Nephrol (2015) 0.87
Allograft outcomes in outbred mice. Am J Transplant (2013) 0.85
Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol (2016) 0.85
Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A. Clin Exp Immunol (2012) 0.84
Identifying biomarkers as diagnostic tools in kidney transplantation. Expert Rev Mol Diagn (2011) 0.83
Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res (2016) 0.82
Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype. Clin Transplant (2013) 0.82
Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol (2016) 0.81
The Interplay between inflammation and fibrosis in kidney transplantation. Biomed Res Int (2014) 0.81
Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation. Fibrogenesis Tissue Repair (2014) 0.80
Monocyte implication in renal allograft dysfunction. Clin Exp Immunol (2014) 0.79
Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling. Transplant Rev (Orlando) (2014) 0.79
Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight (2016) 0.78
Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant (2016) 0.77
Diffusion weighted imaging and diffusion tensor imaging in the evaluation of transplanted kidneys. Eur J Radiol Open (2015) 0.77
The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury. Transplantation (2016) 0.77
Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol (2014) 0.77
Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients. Ther Clin Risk Manag (2015) 0.77
Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury. BMC Genomics (2013) 0.77
New Magnetic Resonance Imaging Index for Renal Fibrosis Assessment: A Comparison between Diffusion-Weighted Imaging and T1 Mapping with Histological Validation. Sci Rep (2016) 0.76
Purinergic signaling in scarring. FASEB J (2015) 0.76
Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney. World J Transplant (2015) 0.76
Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study. Transplant Direct (2016) 0.75
Computational Biology: Modeling Chronic Renal Allograft Injury. Front Immunol (2015) 0.75
High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study. Dis Markers (2015) 0.75
IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES. Trans Am Clin Climatol Assoc (2016) 0.75
Fibrosis with inflammation is associated with reduced graft function and survival. Nat Rev Nephrol (2011) 0.75
Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach. Sci Rep (2017) 0.75
Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels. Transplant Direct (2015) 0.75
A new clinical prediction tool for 5-year kidney transplant outcome. Am J Kidney Dis (2014) 0.75
Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients. PLoS One (2016) 0.75
Identifying common genes and networks in multi-organ fibrosis. AMIA Jt Summits Transl Sci Proc (2012) 0.75
Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function. Int Urol Nephrol (2017) 0.75
Polyclonal Regulatory T cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant (2017) 0.75
Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol (2009) 11.63
TLR signaling pathways. Semin Immunol (2004) 9.08
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol (2008) 6.56
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant (2004) 4.06
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35
Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics (2004) 2.31
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 2.27
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant (2009) 1.83
Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant (2005) 1.79
Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol (1998) 1.54
GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis (1997) 1.54
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant (2006) 1.50
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant (2005) 1.37
Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant (2005) 1.25
Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant (2009) 1.21
Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation (2007) 1.21
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int (2007) 1.17
The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant (2006) 1.17
Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med (2007) 1.10
SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant (2007) 1.10
Long-term deterioration of kidney allograft function. Am J Transplant (2005) 1.09
The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol (2003) 1.09
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant (2007) 1.08
CD14, new aspects of ligand and signal diversity. Microbes Infect (2000) 1.07
Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant (2008) 1.06
Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol (2009) 1.03
Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant (2006) 1.03
The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant (2008) 1.01
Gene expression during acute allograft rejection: novel statistical analysis of microarray data. Am J Transplant (2002) 1.01
Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transpl Int (2008) 1.01
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrol Dial Transplant (2009) 1.00
Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant (2009) 0.99
A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics (2007) 0.98
Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant (2007) 0.96
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation (2007) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med (2008) 0.94
Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol (2003) 0.93
Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation (2009) 0.93
Genetic polymorphisms and the fate of the transplanted organ. Transplant Rev (Orlando) (2008) 0.92
Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant (2005) 0.90
Chronic allograft nephropathy. Curr Opin Nephrol Hypertens (2008) 0.90
Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics (2008) 0.89
Renal transplantation: a half century of success and the long road ahead. J Am Soc Nephrol (2004) 0.89
Using gene arrays in diagnosis of rejection. Curr Opin Organ Transplant (2009) 0.87
Chronic allograft nephropathy. Pediatr Nephrol (2008) 0.85
Signal transduction pathways involved in brain death-induced renal injury. Am J Transplant (2009) 0.84
Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation (1996) 0.81
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol (2011) 2.72
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28
Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol (2008) 2.26
MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int (2005) 2.25
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis (2008) 2.12
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10
The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med (2010) 2.06
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92
Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
The renal mononuclear phagocytic system. J Am Soc Nephrol (2011) 1.84
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int (2013) 1.79
Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant (2005) 1.79
Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther (2011) 1.76
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int (2005) 1.73
Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation (2006) 1.69
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Myeloproliferative neoplasms cause glomerulopathy. Kidney Int (2011) 1.62
Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med (2006) 1.61
Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol (2011) 1.58
Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis (2010) 1.57
Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol (2010) 1.57
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant (2010) 1.57
A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int (2005) 1.52
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant (2011) 1.51
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant (2005) 1.51
Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation (2009) 1.47
Case records of the Massachusetts General Hospital. Case 27-2008. A 64-year-old man with abdominal pain, nausea, and an elevated level of serum creatinine. N Engl J Med (2008) 1.46
Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol (2010) 1.45
Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int (2012) 1.45
Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant (2005) 1.37
Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol (2011) 1.34
Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant (2003) 1.29
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation (2004) 1.29
Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol (2011) 1.29
The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol (2012) 1.29
Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int (2008) 1.27
Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol (2009) 1.27
Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int (2010) 1.24
C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis (2013) 1.24
Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation (2008) 1.23
Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant (2005) 1.20
Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am J Kidney Dis (2012) 1.19
Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem (2003) 1.19
Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol (2013) 1.19
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation (2005) 1.17
Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation (2007) 1.17
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol (2007) 1.16
Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc (2011) 1.15
Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant (2003) 1.13
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol (2005) 1.11
Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene. J Appl Physiol (1985) (2005) 1.11
Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10
Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol (2010) 1.10
Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes (2011) 1.09
Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int (2003) 1.08
Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant (2006) 1.06
Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant (2008) 1.05
Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J Clin Invest (2006) 1.05
Radiological reasoning: male breast mass with calcifications. AJR Am J Roentgenol (2005) 1.05
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation (2003) 1.04
Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis (2008) 1.03
Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant (2004) 1.01
HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc (2007) 1.01
Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun (2002) 0.99
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation (2010) 0.99